Elsalys Biotech

Develops therapeutic monoclonal antibodies for cancer and inflammatory diseases

placeLyon, Auvergne Rhone Alpes, France calendar_todayFounded 2013 groups14 employees language elsalysbiotech.com

Innovation

3 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 155 times.

YearFilings
20161
20172
20183
20191
20201
20211

Investor mix

3 investors on record; 1 has since exited.

Investor typeCountShare
Private equity133%
Bank & private debt133%
Other / undisclosed133%
Coming soon